1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of BHLHE41 mRNA CTD PMID:21983209 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of BHLHE41 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of BHLHE41 mRNA CTD PMID:15576828 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of BHLHE41 mRNA CTD PMID:17351261 17beta-estradiol multiple interactions ISO RGD:731061 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BHLHE41 mRNA more ... CTD PMID:17404688 more ... 17beta-estradiol increases expression ISO RGD:731061 6480464 Estradiol results in increased expression of BHLHE41 mRNA CTD PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:731061 6480464 2 more ... CTD PMID:19095052 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BHLHE41 mRNA CTD PMID:22808131 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731062 6480464 Tetrachlorodibenzodioxin results in increased expression of BHLHE41 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731062 6480464 Tetrachlorodibenzodioxin affects the expression of BHLHE41 mRNA CTD PMID:26377647 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:731061 6480464 3 more ... CTD PMID:23146750 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-sulfonyldiphenol decreases expression ISO RGD:731061 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of BHLHE41 mRNA CTD PMID:30616060 4,4'-sulfonyldiphenol decreases expression ISO RGD:731062 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of BHLHE41 mRNA CTD PMID:33297965 4-hydroxynon-2-enal increases expression ISO RGD:731062 6480464 4-hydroxy-2-nonenal results in increased expression of BHLHE41 mRNA CTD PMID:19191707 5-fluorouracil affects response to substance ISO RGD:731061 6480464 BHLHE41 protein affects the susceptibility to Fluorouracil CTD PMID:16217747 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BHLHE41 mRNA CTD PMID:24780913 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of BHLHE41 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:731061 6480464 Aflatoxin B1 results in decreased methylation of BHLHE41 gene CTD PMID:27153756 all-trans-retinoic acid increases expression ISO RGD:731061 6480464 Tretinoin results in increased expression of BHLHE41 mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BHLHE41 mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:731061 6480464 Antirheumatic Agents results in increased expression of BHLHE41 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:731061 6480464 aristolochic acid I results in decreased expression of BHLHE41 mRNA CTD PMID:33212167 benzo[a]pyrene increases expression ISO RGD:731061 6480464 Benzo(a)pyrene results in increased expression of BHLHE41 mRNA CTD PMID:32234424 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BHLHE41 mRNA CTD PMID:18164116 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of BHLHE41 mRNA CTD PMID:16648578 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BHLHE41 mRNA CTD PMID:25181051 bisphenol A affects methylation ISO RGD:731062 6480464 bisphenol A affects the methylation of BHLHE41 promoter CTD PMID:27334623 butanal increases expression ISO RGD:731061 6480464 butyraldehyde results in increased expression of BHLHE41 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:731061 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BHLHE41 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:731061 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of BHLHE41 mRNA CTD PMID:35301059 cannabidiolic acid increases expression ISO RGD:731061 6480464 cannabidiolic acid results in increased expression of BHLHE41 mRNA CTD PMID:25242400 cantharidin decreases expression ISO RGD:731062 6480464 Cantharidin results in decreased expression of BHLHE41 mRNA CTD PMID:36907384 carbon nanotube decreases expression ISO RGD:731062 6480464 Nanotubes, Carbon results in decreased expression of BHLHE41 mRNA CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of BHLHE41 mRNA CTD PMID:18500788 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of BHLHE41 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:731062 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene CTD PMID:20938992 cisplatin multiple interactions ISO RGD:731061 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of BHLHE41 mRNA, [Cisplatin co-treated with panobinostat] affects the expression of BHLHE41 mRNA CTD PMID:21791302 , PMID:27392435 cisplatin decreases expression ISO RGD:731061 6480464 Cisplatin results in decreased expression of BHLHE41 mRNA CTD PMID:27392435 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BHLHE41 mRNA CTD PMID:22023808 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of BHLHE41 mRNA CTD PMID:17602206 crocidolite asbestos decreases expression ISO RGD:731061 6480464 Asbestos, Crocidolite results in decreased expression of BHLHE41 mRNA CTD PMID:24160326 dexamethasone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BHLHE41 mRNA] CTD PMID:20032058 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BHLHE41 mRNA CTD PMID:20032058 dichloroacetic acid increases expression ISO RGD:731062 6480464 Dichloroacetic Acid results in increased expression of BHLHE41 mRNA CTD PMID:28962523 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of BHLHE41 mRNA CTD PMID:21161181 dimethylarsinic acid multiple interactions ISO RGD:731062 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:34876320 dimethylarsinous acid decreases expression ISO RGD:731061 6480464 dimethylarsinous acid results in decreased expression of BHLHE41 mRNA CTD PMID:23876855 dioxygen multiple interactions ISO RGD:731061 6480464 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... CTD PMID:24403227 dioxygen increases expression ISO RGD:731061 6480464 Oxygen deficiency results in increased expression of BHLHE41 mRNA CTD PMID:24236059 more ... diuron decreases expression EXP 6480464 Diuron results in decreased expression of BHLHE41 mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:731061 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE41 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:731061 6480464 Doxorubicin results in decreased expression of BHLHE41 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BHLHE41 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:731062 6480464 epoxiconazole results in decreased expression of BHLHE41 mRNA CTD PMID:35436446 ethanol multiple interactions ISO RGD:731061 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:23378141 ethanol increases expression ISO RGD:731061 6480464 Ethanol results in increased expression of BHLHE41 mRNA CTD PMID:23378141 fenamidone increases expression ISO RGD:731062 6480464 fenamidone results in increased expression of BHLHE41 mRNA CTD PMID:27029645 folic acid multiple interactions ISO RGD:731062 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene CTD PMID:20938992 folic acid increases expression ISO RGD:731062 6480464 Folic Acid results in increased expression of BHLHE41 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:731061 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:23378141 genistein increases expression ISO RGD:731062 6480464 Genistein results in increased expression of BHLHE41 mRNA CTD PMID:32186404 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BHLHE41 mRNA CTD PMID:33387578 ketamine increases expression EXP 6480464 Ketamine results in increased expression of BHLHE41 mRNA CTD PMID:20080153 L-methionine multiple interactions ISO RGD:731062 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BHLHE41 gene CTD PMID:20938992 lipopolysaccharide decreases expression ISO RGD:731062 6480464 Lipopolysaccharides results in decreased expression of BHLHE41 mRNA CTD PMID:25890327 lipopolysaccharide multiple interactions ISO RGD:731061 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BHLHE41 mRNA] CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:731061 6480464 Lipopolysaccharides results in increased expression of BHLHE41 mRNA CTD PMID:35811015 methylarsonic acid multiple interactions ISO RGD:731062 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:34876320 methylmercury chloride increases expression ISO RGD:731061 6480464 methylmercuric chloride results in increased expression of BHLHE41 mRNA CTD PMID:28001369 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BHLHE41 mRNA CTD PMID:16026605 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BHLHE41 mRNA CTD PMID:18164116 nickel atom decreases expression ISO RGD:731061 6480464 Nickel results in decreased expression of BHLHE41 mRNA CTD PMID:24768652 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BHLHE41 mRNA CTD PMID:22110744 O-methyleugenol increases expression ISO RGD:731061 6480464 methyleugenol results in increased expression of BHLHE41 mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BHLHE41 mRNA CTD PMID:25729387 panobinostat multiple interactions ISO RGD:731061 6480464 [Cisplatin co-treated with panobinostat] affects the expression of BHLHE41 mRNA CTD PMID:21791302 paracetamol affects expression ISO RGD:731062 6480464 Acetaminophen affects the expression of BHLHE41 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:731061 6480464 Acetaminophen results in increased expression of BHLHE41 mRNA CTD PMID:29067470 pentanal increases expression ISO RGD:731061 6480464 pentanal results in increased expression of BHLHE41 mRNA CTD PMID:26079696 phenobarbital affects expression ISO RGD:731061 6480464 Phenobarbital affects the expression of BHLHE41 mRNA CTD PMID:19159669 phenylmercury acetate increases expression ISO RGD:731061 6480464 Phenylmercuric Acetate results in increased expression of BHLHE41 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:731061 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE41 mRNA CTD PMID:27188386 potassium dichromate increases expression ISO RGD:731062 6480464 Potassium Dichromate results in increased expression of BHLHE41 mRNA CTD PMID:23608068 progesterone multiple interactions ISO RGD:731061 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BHLHE41 mRNA, [Progesterone co-treated with Estradiol] results in decreased expression of BHLHE41 mRNA CTD PMID:17404688 , PMID:20660070 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of BHLHE41 mRNA CTD PMID:20726854 propanal increases expression ISO RGD:731061 6480464 propionaldehyde results in increased expression of BHLHE41 mRNA CTD PMID:26079696 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BHLHE41 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:731061 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of BHLHE41 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:731061 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BHLHE41 mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:731061 6480464 Asbestos, Serpentine results in decreased expression of BHLHE41 mRNA CTD PMID:24160326 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of BHLHE41 mRNA CTD PMID:15967596 silicon dioxide increases expression ISO RGD:731061 6480464 Silicon Dioxide analog results in increased expression of BHLHE41 mRNA, Silicon Dioxide results in increased expression of BHLHE41 mRNA CTD PMID:22300531 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of BHLHE41 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:731062 6480464 Silicon Dioxide results in increased expression of BHLHE41 mRNA CTD PMID:29203145 sodium arsenate multiple interactions ISO RGD:731062 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:34876320 sodium arsenite decreases expression ISO RGD:731061 6480464 sodium arsenite results in decreased expression of BHLHE41 mRNA CTD PMID:34032870 sodium arsenite multiple interactions ISO RGD:731062 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in increased expression of BHLHE41 mRNA CTD PMID:34876320 Soman increases expression EXP 6480464 Soman results in increased expression of BHLHE41 mRNA CTD PMID:19281266 sunitinib increases expression ISO RGD:731061 6480464 Sunitinib results in increased expression of BHLHE41 mRNA CTD PMID:31533062 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of BHLHE41 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in decreased expression of BHLHE41 mRNA] CTD PMID:20032058 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BHLHE41 mRNA CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BHLHE41 mRNA CTD PMID:30723492 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BHLHE41 mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:731062 6480464 titanium dioxide results in decreased expression of BHLHE41 mRNA CTD PMID:29264374 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of BHLHE41 mRNA CTD PMID:30012374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of BHLHE41 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of BHLHE41 mRNA CTD PMID:25729387 tributylstannane increases expression ISO RGD:731062 6480464 tributyltin results in increased expression of BHLHE41 mRNA CTD PMID:31939706 trichloroethene increases expression ISO RGD:731062 6480464 Trichloroethylene results in increased expression of BHLHE41 mRNA CTD PMID:28973375 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BHLHE41 mRNA CTD PMID:33387578 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of BHLHE41 mRNA CTD PMID:21515302 undecane increases expression EXP 6480464 undecane results in increased expression of BHLHE41 protein CTD PMID:17337753 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BHLHE41 mRNA CTD PMID:22615374 more ... vorinostat decreases expression ISO RGD:731061 6480464 vorinostat results in decreased expression of BHLHE41 mRNA CTD PMID:27188386